6-K/A

AMENDMENT NO. 2

Company: Biodexa Pharmaceuticals Plc
Filed: May 26, 2023
Period of Report: May 25, 2023
Accession Number: 0001214659-23-007852

View Document ↗ View on SEC.gov ↗